Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort
Conversion therapy with curative intent following HAIC or ICIs might enhance survival in patients with advanced or TACE-unsuitable intermediate-stage HCC.
Authors
- Fu‐Huan Huang (ORCID: https://orcid.org/0000-0002-2747-2900)
- Wen‐Chun Liu (ORCID: https://orcid.org/0000-0003-0344-4371)
- Li‐Fu Kuo
- Chu‐Kuang Chou (ORCID: https://orcid.org/0000-0003-2588-6883)
- Mingfeng Li (ORCID: https://orcid.org/0000-0003-3472-9070)
- Yi-Tseng Tsai
- I‐Ting Wu (ORCID: https://orcid.org/0000-0002-4003-2766)
- Kun‐Feng Tsai (ORCID: https://orcid.org/0000-0002-1431-8250)
- Tsung‐Hsien Chen (ORCID: https://orcid.org/0000-0002-1542-1495)
- Chao-Jen Li
- Ping‐I Hsu (ORCID: https://orcid.org/0000-0003-3905-4674)
Institutions
- National Tainan Institute of Nursing (TW)
- China Medical University (TW)
- Taipei Medical University Hospital (TW)
- An-Nan Hospital (TW)
- Chia-Yi Christian Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- Chang Jung Christian University (TW)
Publication Details
- Journal
- Oncology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1159/000542291
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74